when 50 percent or greater improvement of pain/tenderness scores were compared for end of trial versus entry values , 9 percent of placebo-treated patients , 34 percent of auranofin-treated patients , and 48 percent of gold sodium thiomalate-treated patients showed important improvement that was statistically significant for both gold treatments .
C0018034
gold sodium thiomalate
C0018026
gold